Gilead Sciences Dividend yield

Gilead Sciences is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Gilead Sciences is a company from USA, and his stocks are publicly traded.

Gilead Sciences stock dividend

Gilead Sciences paid a total dividend of 3,762 million USD last year, for a market value of 96,483 millions (Market Cap 96,486 millions). Gilead Sciences dividend per share is 3.00 USD, and his stock market price 76.94 USD.

According to the chart below, where dividend yield is displayed, Gilead Sciences has a dividend yield of 3.90%, which is higher than the amount offered by both the market average and companies from USA. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Gilead Sciences stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high USA dividend stocks list.

Gilead Sciences Dividend Payout

About the ability of Gilead Sciences to maintain his current dividend of USD 3.00 per share, an amount that accounts for 3.90%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Gilead Sciences payout on ernings is currently 58.82%, which is higher than the market average, and companies of Health Care industry, which are 39.87% and 21.91% respectively. Both figures show that Gilead Sciences can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Gilead Sciences is USD 7.26 per share, which is higher than the dividend per share paid by the company of USD 3.00, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Gilead Sciences, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Gilead Sciences Dividend History

Below you will find a table with the historical evolution of Gilead Sciences's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	3.90%	3.00	58.82%	1,254
2022	3.40%	2.92	46.28%	1,254
2021	3.91%	2.84	267.92%	1,254
2020	4.67%	2.72	52.31%	1,254
2019	3.88%	2.52	48.09%	1,275
2018	3.65%	2.28	26.60%	1,300
2017	2.90%	2.08	18.87%	1,307
2016	2.55%	1.88	13.27%	1,332
2015	0.81%	0.86	9.49%	1,441

*In millions

Then you can see the evolution of Gilead Sciences dividend stock, and compare it with the average of USA stocks and that of the Pharmaceuticals and Biotechnology stocks.

Gilead Sciences Stock performance

Finally, last moth Gilead Sciences showed a return of -6.40% compared to a worldwide -2.16% average, and a -3.16% of Health Care firms. Over the last year, the company obtained a 18.60% versus a worldwide performance of a 0.43%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.